News

News
1 May 2020 Compassionate use programs – COVID-19 authorized by AIFA Compassionate use programs – COVID-19 authorized by AIFA SOLNATIDE, the therapeutic molecule solnatide developed by APEPTICO… Read more
28 April 2020 Apeptico press release SOLNATIDE has been approved for the treatment of COVID-19 patients suffering from pulmonary oedema and… Read more
30 March 2020 OPIS: In the front line in the fight against COVID-19 The spread of Coronavirus continues both in Italy and globally. For this reason, in order… Read more
16 October 2019 Reshaping the future of adequate care The paradigm of treating disease has shifted. Today, we are exploring options where personalized… Read more
29 May 2019 The Patient Data Paradigm The Patient Data Paradigm Precision medicine and personalised treatment options have become a reality in… Read more
13 October 2018 Data Managers are worth their weight in gold The value of experienced data managers is priceless. Please click on the link to… Read more
10 October 2017 A suited approach to rare disease trials OPIS is currently involved in a phase II project for an ultra rare disease…. Read more
Call us